All you ever wanted to know about naming

Coming Soon: Linguistic analysis on fashion brand names

Wednesday, May 26, 2010

Quensis and Solutions Consulting sign partnership agreement to market Quensis’ new naming offer, C-QUENS, in Egypt

Tuesday, May 25, 2010

Cairo – May 12, 2010
Solutions Consulting (SC), a well-established business consulting organization, recognized in Egypt and across the Middle East / North Africa region, provides world-class consultancy through its three business units: Integrated Marketing Solutions, Advance Corporate Solutions as well as Training and Education Programs. Their consulting expertise covers the whole spectrum of marketing and [...]

Creating a name for both France and arabic countries is quite a linguistic challenge

Monday, March 1, 2010

From a doctor’s standpoint, a good drug name needs to be easy to pronounce, easy to write and easy to remember. And of course, without any negative connotations. These requirements become harder to satisfy; and especially when a name should fit several different markets, linguistic difficulties multiply.

Créer un nom de médicament pour la France et les pays arabes : un challenge linguistique

Monday, March 1, 2010

Pour les médecins, un bon nom de médicament doit être facile à prononcer, à retenir et à écrire. Il ne doit pas présenter de connotations négatives. Quand un nom doit servir plusieurs marchés, les difficultés linguistiques se multiplient.

Quensis signs 2 new drug names in gastroenterology and in cardiology

Wednesday, January 13, 2010

ZANEXTRA: An anti-hypertension of a new generation, the successor of Zanidip. The objective was to underline the affiliation with the previous drug but also message the superiority of the new improved version. 

GASTROWELL: An anti-diarrheal and an anti-inflammatory, two versions of the same OTC product. The name had to be simple and easily memorable for both [...]

Quensis signe 2 nouveaux noms de médicaments en gastro-entérologie et en cardiologie

Wednesday, January 13, 2010

ZANEXTRA : Un anti-hypertenseur de nouvelle génération, le successeur de Zanidip. L’impératif pour le nouveau nom : marquer cette filiation mais aussi sa supériorité par rapport au précédent médicament.

GASTROWELL : Un anti-diarrhéique et un anti-inflammatoire, deux versions du même produit de conseil. Deux mots d’ordre pour la création du nom: simplicité et appropriation facile pour les [...]

WIPO Seminar on Innovation

Wednesday, September 23, 2009

On May 12 and 13, Quensis was invited to speak at a seminar on marks and reputation, along with the French IP office, in cooperation with the Chinese IP office, SAIC. Delphine Parlier spoke to Chinese officials and industrial magnates on how Chinese corporations can best select ideal brand names that fit the global market’s cultural and legal requirements [...]

Coming Soon: a brainstorming enhancer for Agencies

Tuesday, September 22, 2009

74,800 domains contain SPRING

Monday, September 21, 2009

A March 2008 analysis of the database of .COM registered names shows the following share of Internet presence for each season: 74,800 domains contain SPRING (51%), 25,500 domains contain SUMMER (18%), 24,600 domains contain FALL (17%), 20,300 domain contain WINTER (14%) [...]

When a domain name duplicates an existing trademark

Monday, September 21, 2009

Many domain name disputes concern the abusive use of existing trademarks by third parties. Cybersquatters exploit the first-come, first-served principle of the domain name registration system. Initially, the Internet suffered from an absence of international legal standards for resolving these disputes [...]


About QUENSIS

Quensis is a company specialized in name creation. Our specificity is to create names with very strong likelihood of availability.
Quensis is based on a proprietary technology, unique in the world, which integrates the legal parameter into the creative process and makes it possible to create names that are commercially exploitable.